Single low-dose lipopolysaccharide preconditioning: neuroprotective against axonal injury and modulates glial cells

AIM: Over 7 million traumatic brain injuries (TBI) are reported each year in the United States. However, treatments and neuroprotection following TBI are limited because secondary injury cascades are poorly understood. Lipopolysaccharide (LPS) administration before controlled cortical impact can con...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Ryan C., Naser, Zachary J., Lucke-Wold, Brandon P., Logsdon, Aric F., Vangilder, Reyna L., Matsumoto, Rae R., Huber, Jason D., Rosen, Charles L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289820/
https://www.ncbi.nlm.nih.gov/pubmed/28164149
http://dx.doi.org/10.20517/2347-8659.2016.40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289820/
https://www.ncbi.nlm.nih.gov/pubmed/28164149
http://dx.doi.org/10.20517/2347-8659.2016.40

Ejemplares similares